Bank of Nova Scotia’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,026
Closed -$297K 1052
2024
Q3
$297K Buy
3,026
+989
+49% +$128K ﹤0.01% 917
2024
Q2
$333K Sell
2,037
-91
-4% -$13K ﹤0.01% 908
2024
Q1
$324K Buy
2,128
+1,157
+119% +$193K ﹤0.01% 915
2023
Q4
$305K Buy
+971
New +$351K ﹤0.01% 942

Other funds holding AGL

Bank of Nova Scotia's AGL Position: Q4 2024 in Review

Bank of Nova Scotia sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 3,026 shares — an estimated $297K sold.

Bank of Nova Scotia first reported a position in AGL in Q4 2023 and held it in 4 quarters. The position peaked at $333K in Q2 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

  • Bank of Nova Scotia reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
  • Bank of Nova Scotia sold 3,026 Agilon Health shares in Q4 2024, an estimated $297K.
  • Bank of Nova Scotia first reported a position in Agilon Health in Q4 2023 and held it in 4 quarters.
  • Bank of Nova Scotia's Agilon Health position peaked at $333K in Q2 2024.
  • 184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Bank of Nova Scotia's 13F filing for Q4 2024, filed 13 Feb 2025.